Bristol-Myers Squibb to Take Part at the Citi 2016 Global Healthcare Conference

Bristol-Myers Squibb Company (NYSE: BMY) will take part in the Citi 2016 Global Healthcare Conference on Wednesday, December 7, 2016, in New York. Giovanni Caforio, M.D., chief executive officer, and Francis Cuss, MB, BChir, FRCP, chief scientific officer, will make formal remarks and answer questions about the company at 8:00 a.m. EST. Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161130005845/en/